The estimated Net Worth of Raymond W. Scott is at least $2.88 Миллион dollars as of 4 June 2020. Mr. Scott owns over 2,028 units of iRhythm Technologies Inc stock worth over $132,000 and over the last 8 years he sold IRTC stock worth over $2,567,654. In addition, he makes $175,987 as Independent Director at iRhythm Technologies Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Scott IRTC stock SEC Form 4 insiders trading
Raymond has made over 7 trades of the iRhythm Technologies Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 2,028 units of IRTC stock worth $261,612 on 4 June 2020.
The largest trade he's ever made was selling 52,903 units of iRhythm Technologies Inc stock on 7 August 2017 worth over $2,306,042. On average, Raymond trades about 6,843 units every 74 days since 2016. As of 4 June 2020 he still owns at least 1,764 units of iRhythm Technologies Inc stock.
You can see the complete history of Mr. Scott stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Raymond Scott biography
Raymond W. Scott serves as Independent Director of the Company. Mr. Scott has been the Chairman of the board at Health Level, Inc., since January 2013. He has served as a member of the board of directors of Health Fidelity, Inc. since August 2013, as a member of the board of directors at Stella Technologies, Inc., a healthcare technology provider, since October 2015, and as a member of the board of directors of Empatica, Inc. since October 2019. Mr. Scott co-founded Axolotl Corporation in 1995 and served as its Chief Executive Officer until its acquisition by United Health Group in August 2010, at which point he became Executive Vice President of Product Strategy for OptumInsight, Inc., a subsidiary of United Health Group. Mr. Scott is a Member of the British Computing Society (MBCS), a Chartered Engineer and holds a B.Sc. (Honors) in Mathematics.
What is the salary of Raymond Scott?
As the Independent Director of iRhythm Technologies Inc, the total compensation of Raymond Scott at iRhythm Technologies Inc is $175,987. There are 11 executives at iRhythm Technologies Inc getting paid more, with Kevin King having the highest compensation of $4,774,140.
How old is Raymond Scott?
Raymond Scott is 73, he's been the Independent Director of iRhythm Technologies Inc since 2013. There are 1 older and 22 younger executives at iRhythm Technologies Inc. The oldest executive at iRhythm Technologies Inc is Ralph Snyderman, 80, who is the Independent Director.
What's Raymond Scott's mailing address?
Raymond's mailing address filed with the SEC is 650 Townsend St # 500, San Francisco, CA 94103, USA.
Insiders trading at iRhythm Technologies Inc
Over the last 8 years, insiders at iRhythm Technologies Inc have traded over $124,847,276 worth of iRhythm Technologies Inc stock and bought 150,000 units worth $2,550,000 . The most active insiders traders include Holdings A/S Novo, Vijay K Lathi и Kevin M King. On average, iRhythm Technologies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $1,872,546. The most recent stock trade was executed by Brice Bobzien on 9 August 2024, trading 1,372 units of IRTC stock currently worth $96,506.
What does iRhythm Technologies Inc do?
irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
What does iRhythm Technologies Inc's logo look like?
Complete history of Mr. Scott stock trades at iRhythm Technologies Inc
iRhythm Technologies Inc executives and stock owners
iRhythm Technologies Inc executives and other stock owners filed with the SEC include:
-
Kevin King,
President, Chief Executive Officer, Director -
David Vort,
Executive Vice President - Sales -
Mark Day,
Executive Vice President of Research and Development -
Kevin M. King,
Consultant & Director -
Matthew C. Garrett,
Advisor -
Daniel G. Wilson,
Exec. VP of Strategy, Corp. Devel. & Investor Relations -
Douglas J. Devine,
COO, CFO & Sec. -
David A. Vort,
Exec. VP of Sales & Chief Commercial Officer -
Mark J. Day Ph.D.,
Exec. VP of R&D -
Abhijit Talwalkar,
Independent Chairman of the Board -
Mark Rubash,
Independent Director -
Raymond Scott,
Independent Director -
Bruce Bodaken,
Independent Director -
Ralph Snyderman,
Independent Director -
Cathleen Noel Merz,
Independent Director -
Douglas Devine,
Chief Financial Officer -
Renee Budig,
Independent Director -
Mazi Kiani,
Sr. VP of Quality & Regulatory -
Dietra N. Jones,
Exec. VP of Clinical Operations -
Reyna M. Fernandez,
Exec. VP & Chief HR Officer -
Dr. Mintu P. Turakhia M.D.,
Chief Medical Officer & Chief Scientific Officer -
Allan B. Wilsker,
Exec. VP of Information Technology & Customer Service -
Patrick Michael Murphy J.D.,
Gen. Counsel -
Quentin S. Blackford,
Pres & CEO -
Judith C. Lenane,
Chief Clinical Officer & Exec. VP of Operations -
Kaja J. Odegard,
VP of HR -
Marga Ortigas-Wedekind,
Exec. VP of Marketing -
Michael J. Coyle,
Pres, CEO & Director -
Tiba Aynechi,
Director -
Life Science Partners L P S...,
-
Venture Partners Xi, Lp Cro...,
-
Matthew C. Garrett,
Chief Financial Officer -
Life Science Partners L P S...,
-
Holdings A/S Novo,
10% owner -
Clercq Casper L. De,
Director -
Michael J Coyle,
President and CEO -
Vijay K Lathi,
Director -
Karim Karti,
Former Chief Operating Officer -
Derrick Sung,
EVP, Strat Corp Development -
Mojdeh Poul,
Director -
Brian B Yoor,
Director -
Karen Ling,
Director -
Mervin Smith,
EVP Strategic Business Ops -
Marc W. Rosenbaum,
Chief Accounting Officer -
Daniel G. Wilson,
EVP, Corp Dev Inv Rel -
Brice Bobzien,
Chief Financial Officer -
Quentin S. Blackford,
President and CEO -
Minang Turakhia,
EVP, CMO & CSO -
Reyna M Fernandez,
EVP, Chief HR Officer -
Chad Patterson,
Chief Commercial Officer -
Sumi Shrishrimal,
EVP, Chief Risk Officer -
Patrick Michael Murphy,
CBO and CLO